Industries > Pharma > Global Pharma Contract Sales Market Forecast 2020-2030

Global Pharma Contract Sales Market Forecast 2020-2030

Contract Detailing, Contract Non-personal Promotion, Medical Education Services, Sample Management Services, Tele-detailing Services, E-detailing Services, Cardiovascular Disease, Metabolic Disorders, Oncology

PUBLISHED: 26 February 2020
PAGES: 244
PRODUCT CODE: PHA0718
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0718 Categories: , Tags: , ,

covid-19

The global pharma contract sales market is expected to grow at a CAGR of 7.9% in the first half of the forecast period. In 2019, the contract detailing segment held 76% of the global pharma contract sales market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 244-page report you will receive 77 tables and 62 figures– all unavailable elsewhere.

The 244-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pharma Contract Sales Market forecasts from 2020-2030

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2030 for the following submarket by leading services:
• Contract detailing (personal promotion/field sales)
• Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
• Medical education services
• Sample management services

• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
• Cardiovascular disease
• Metabolic disorders
• Oncology
• Other

• This report provides individual revenue forecasts to 2030 for these regional and national markets:
• US
• Japan
• EU5: Germany, UK, France, Italy and Spain
• BRIC: China, India, Brazil and Russia

The US, Japan, EU5 and BRIC markets are further segmented by therapeutic segments and leading services

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study also discusses factors that will drive and restrain the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market:
• Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
Services CSOs offer and benefits to drug companies outsourcing medical sales
• Maturing brands and product launches, including flexibility in field sales teams
Legislation and new market access requirements for pharma sales representatives
• Changes to online marketing and potential for IT technologies Risk-sharing agreements
Key account management (KAM) and medical science liaison (MSL)

• This report discusses the leading companies in pharma contract sales:
• Apodi
• CMIC
• inVentiv Health (Syneos Health)
• IQVIA
• Marvecs
• OnCall, LLC
• Publicis Healthcare Communications Group
• Sofip
• Star Healthcare
• UDG Healthcare

• Key questions answered by this report:
• How much is the global pharma contract sales market currently worth, and how much will it be worth during the period 2020-2030?
• What are the leading therapeutic submarkets from 2020-2030?
• What are the leading services submarkets from 2020-2030?
• What are the leading national markets and the leading emerging markets from 2020-2030? What are the regulatory landscapes in these nations?
• What are the main trends that will shape this market over the next ten years, and the main drivers and restraints?
• Who are the leading CSOs in this market?

Visiongain’s study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions.

Buy our report today Global Pharma Contract Sales Market Forecast: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services, Cardiovascular Disease, Metabolic Disorders, Oncology.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Categories